Range Low Price High Price Comment
30 days $14.08 $21.88 Thursday, 28th Mar 2024 MGNX stock ended at $14.72. This is 1.60% less than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 6.77% from a day low at $14.29 to a day high of $15.25.
90 days $9.33 $21.88
52 weeks $4.29 $21.88

Historical MacroGenics prices

Date Open High Low Close Volume
2024-03-28 $14.74 $15.25 $14.29 $14.72 771 111
2024-03-27 $14.33 $14.99 $14.30 $14.96 900 505
2024-03-26 $14.59 $14.72 $14.19 $14.22 753 682
2024-03-25 $14.46 $14.56 $14.08 $14.41 803 155
2024-03-22 $15.51 $15.51 $14.47 $14.48 817 054
2024-03-21 $15.64 $16.18 $15.37 $15.39 669 113
2024-03-20 $15.53 $15.78 $14.89 $15.39 874 865
2024-03-19 $15.42 $15.77 $14.92 $15.58 1 593 211
2024-03-18 $15.80 $16.37 $15.27 $15.60 1 171 225
2024-03-15 $16.02 $16.75 $15.86 $15.93 4 213 605
2024-03-14 $16.32 $16.75 $15.57 $16.06 2 013 191
2024-03-13 $17.50 $17.62 $15.92 $16.56 1 806 154
2024-03-12 $16.86 $17.82 $16.66 $17.60 1 826 002
2024-03-11 $17.15 $18.13 $16.75 $16.94 1 659 482
2024-03-08 $19.34 $21.49 $16.44 $17.43 4 451 711
2024-03-07 $21.59 $21.79 $20.48 $20.51 1 734 230
2024-03-06 $21.07 $21.88 $20.66 $21.47 1 711 909
2024-03-05 $20.79 $21.33 $20.28 $20.64 2 305 682
2024-03-04 $19.78 $20.80 $19.41 $20.72 2 599 652
2024-03-01 $18.06 $19.39 $18.06 $19.06 2 003 422
2024-02-29 $17.84 $18.60 $17.64 $17.94 1 945 356
2024-02-28 $17.22 $17.81 $17.03 $17.19 825 272
2024-02-27 $16.99 $18.52 $16.41 $17.26 1 506 170
2024-02-26 $18.00 $18.47 $16.55 $16.81 1 738 660
2024-02-23 $17.13 $18.19 $17.13 $18.14 1 022 144
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT